Skip to main content
Main menu
Pipeline
Clinical
Discovery
Compounds
Regimens
Drug Targets
Developers
Trial Sites
Trials
News
Meetings
Members
Our Members
Core Group
About
Join Us
Pipelines
Anti-TB
Biologics
Host Directed
View Discovery
Clinical Pipeline
Learn more
about our pipeline
Trials for Market Approval
Download PPT
Advancing
Either
No
Yes
Marketed
On
NCE
On
Repurposed
On
Trials for Market Approval
On
Phase 2
Rifapentine
CDC TBTC, Sanofi
CLO-FAST
Phase 3
Pretomanid
TB Alliance
NC-005
PAN-TB XBQS Trial
NC-009 Trial
Delamanid
Otsuka Pharmaceutical Development & Commercialization, Inc.
Pediatric PK and Safety Trial Delamanid in MDR TB
DECODE- Delpazolid Dose-Finding and Combination Development Trial
Phase 2b/c. 4-month Regimen of OPC-167832, Delamanid and Bedaquiline for DS Pulmonary TB
endTB-Q
PAN-TB XBQS Trial
Bedaquiline
Janssen Research & Development, LLC
NC-005
DECODE- Delpazolid Dose-Finding and Combination Development Trial
Phase 2b/c. 4-month Regimen of OPC-167832, Delamanid and Bedaquiline for DS Pulmonary TB
endTB-Q
PAN-TB XBQS Trial
View Discovery
Trials for Market Approval
Download PPT